Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ivosidenib by Les Laboratoires Servier for Chronic Myelomonocytic Leukemia (CMML): Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase I for Chronic Myelomonocytic Leukemia (CMML). According...
Ivosidenib by Les Laboratoires Servier for Solid Tumor: Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase II for Solid Tumor. According to GlobalData,...
Ivosidenib by Les Laboratoires Servier for Metastatic Bile Duct Cancer: Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase II for Metastatic Bile Duct Cancer. According...
Ivosidenib by Les Laboratoires Servier for Low-Grade Glioma: Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase I for Low-Grade Glioma. According to GlobalData,...
Ivosidenib by Les Laboratoires Servier for Chondrosarcoma: Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase II for Chondrosarcoma. According to GlobalData, Phase...